Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19

NCT04445207 · clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jonathan Gerber